Skip to main content
TipRanks
Go Ultimate75% OFF

Gongwin Biopharm Holdings Co., Ltd. (6617) Cash flow

Gongwin Biopharm Holdings Co., Ltd. Cash Flow

TW:6617's free cash flow for Q2 2026 was NT$-61.11M. For the 2026 fiscal year, TW:6617's free cash flow was decreased by NT$-1.51M and operating cash flow was NT$-59.60M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Mar 24Mar 23Dec 21
NT$ -135.75MNT$ -87.41MNT$ -110.80MNT$ -232.20MNT$ -95.51M
NT$ 600.68MNT$ -1.20BNT$ -280.97MNT$ -202.00MNT$ -246.42M
NT$ -388.61MNT$ 1.88BNT$ -12.10MNT$ 604.05MNT$ 101.77M
NT$ 968.90MNT$ 893.47MNT$ 273.59MNT$ 671.51MNT$ 454.12M
NT$ -138.21MNT$ -293.54MNT$ -111.93MNT$ -238.37MNT$ -95.56M

Currency in TWD

Gongwin Biopharm Holdings Co., Ltd. Cash Flow

-2B-1B01B2B3B2019202020212022202320242025OperatingInvestingFinancing